##  [Novartis highlights research on investigational, personalized T cell therapy CTL019 in patients with forms of acute and chronic leukemia](/us-en/news/media-releases/novartis-highlights-research-investigational-personalized-t-cell-therapy-ctl019-patients-forms-acute-and-chronic-leukemia-0 "Novartis highlights research on investigational, personalized T cell therapy CTL019 in patients with forms of acute and chronic leukemia") 

  Dec 07, 2013